European Parliament debate on embryonic stem cell research funding:
This article was originally published in Clinica
Executive Summary
A lively debate has taken place at the European Parliament on the question of whether stem-cell research should be financed through EU funding. While there are still huge differences of opinion between the MEPs, the scientists and member states, the aim is to achieve an eventual compromise on many of the issues. The European Commission hopes to draw up a proposal for establishing guidelines for deciding on EU funding of research projects involving the use of human embryos and human embryonic stem cells. The EP'sdiscussion is pivotal to the future of medicine: if stem cells can cure some diseases, such as multiple sclerosis (where there has been great success in trials with mice), there will be a significant shift in the need for other interventions and treatments for such diseases in the future.
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.